Multiple Myeloma Forums

Filter  MonthJanFebMarAprMayJunJulAugSepOctNovDec Year20002001200220032004200520062007200820092010 5101520253050100All Filter

• Former BG police officer creates foundation in honor of late wife (Daily Herald)

  Automated News - Automated News

  Created: Sunday, 27 December 2009 01:17

  Connie Sizer spent her life beating the odds. Sizer, who came to America after growing up in extreme hardship in South Korea , lived for nearly 14 years with multiple myeloma, a condition with a median survival rate of only 21/2-3 years.Read more: Yahoo! ...

• Prominent local passings in 2009 included Sales, Barr and Maynard (The Huntington Herald-Dispatch)

  Automated News - Automated News

  Created: Sunday, 27 December 2009 00:01

  The Tri-State lost a number of public servants during 2009 in the areas of law enforcement, education and emergency service. Also among the deaths of the year were business leaders and noted artisans, and beloved public figures.Read more: Yahoo! News Sear...

• Infant Death Support Group meets in Lorain (The Sun Post-Herald)

  Automated News - Automated News

  Created: Saturday, 26 December 2009 14:06

  Infant Death Support Group, Church of St. Peter, 3655 Oberlin Ave., Lorain. 6:30-8 p.m. the second Monday of each month. (440) 282-9380.Read more: Yahoo! News Search Results for Multiple Myeloma...

• Novel Therapeutic Agents May Reduce Kidney Impairment In Newly Diagnosed Myeloma Patients (ASH 2009)

  Automated News - Automated News

  Created: Saturday, 26 December 2009 10:49

  The results from a new study indicate that treatment of newly diagnosed multiple myeloma with novel therapeutic agents improves kidney function in most patients, in comparison to treatment with conventional chemotherapy and a high-dose regimen of dexameth...

• New Health Chief, Same Attack On Smoking, Obesity (NY1 News)

  Automated News - Automated News

  Created: Thursday, 24 December 2009 22:06

  This year was full of medical advances and some setbacks.Read more: Yahoo! News Search Results for Multiple Myeloma...

• Highlights from Mayo Clinic's Discovery's Edge research magazine

  Automated News - Automated News

  Created: Thursday, 24 December 2009 08:30

  Here are highlights from the winter issue of Discovery's Edge, Mayo Clinic's research magazine.Read more: Multiple Myeloma News Feed...

• Operation Holiday: Tabitha and Derek not ready to give up (Daily Record)

  Automated News - Automated News

  Created: Thursday, 24 December 2009 04:19

  Tabitha and Derek are doing their best to raise their special needs children. These dedicated parents (J-11) take on the many challenges their family faces on a daily basis with an unending resolve.Read more: Yahoo! News Search Results for Multiple Myelom...

• Preemptive Treatment Benefits High-Risk Smoldering Myeloma Patients, Study Finds (ASH 2009)

  Automated News - Automated News

  Created: Wednesday, 23 December 2009 17:02

  People with high-risk, smoldering multiple myeloma who are treated with Revlimid (lenalidomide) and dexamethasone (Decadron) take longer to progress to full-blown multiple myeloma than their counterparts, according to interim results of an ongoing Phase 3...

• BioWatch: MedImmune pulls H1N1 vaccine (Gazette.net)

  Automated News - Automated News

  Created: Wednesday, 23 December 2009 16:57

  MedImmune has voluntarily recalled 13 lots of its nasal vaccine for H1N1 flu, saying the doses had lost a "slight" degree of potency.Read more: Yahoo! News Search Results for Multiple Myeloma...

• Discovery's Edge Winter Issue (Newswise)

  Automated News - Automated News

  Created: Wednesday, 23 December 2009 13:49

  Here are highlights from the winter issue of Discovery's Edge, Mayo Clinic's research magazine. 1) Deep Brain Stimulation -- It Boggles the Mind; 2) Osteoporosis in Men; 3) Combat Injuries -- Regenerating the Nerves; 4) Multiple Myeloma and the Genome.Rea...

• Æterna Zentaris terminates agreement with sanofi-aventis US for development, commercialization & licensing of cetrorelix (PharmaBiz)

  Automated News - Automated News

  Created: Wednesday, 23 December 2009 07:43

  Æterna Zentaris Inc, a global biopharmaceutical company focused on oncology and endocrine therapy, announced the termination of its agreement with sanofi-aventis US dated March 5, 2009 for the development, commercialization and licensing of cetrorelix in...

• Cardiac rehabilitation improves survival rate in heart attack patients (News-Medical-Net)

  Automated News - Automated News

  Created: Wednesday, 23 December 2009 00:36

  Medicare beneficiaries with heart disease who attended more cardiac rehabilitation sessions had fewer heart attacks and were less likely to die within four years than those who went to rehab less, researchers report in Circulation: Journal of the American...

• Revlimid Maintenance Therapy Significantly Extends Disease-Free Survival

  Automated News - Automated News

  Created: Tuesday, 22 December 2009 15:42

  Preliminary results from a Phase 3 clinical trial show that multiple myeloma patients who received Revlimid (lenalidomide) following a stem cell transplant had a significantly longer period of disease-free survival compared with a placebo group. The trial...

• Zolinza Combination Treatments Offer Benefit For Multiple Myeloma Patients (ASH 2009)

  Automated News - Automated News

  Created: Tuesday, 22 December 2009 12:56

  The 2009 American Society of Hematology (ASH) Meeting showcased several presentations on Zolinza (vorinostat), a histone deacetylase inhibitor developed by Merck Pharmaceuticals that is currently investigated for the treatment of multiple myeloma. Zolinza...

• Drug for Multiple Myeloma Demonstrated to Significantly Extend Disease-free Survival (Kansas City InfoZine)

  Automated News - Automated News

  Created: Tuesday, 22 December 2009 09:13

  An estimated 20,580 people will be diagnosed with multiple myeloma in the United States in 2009. Approximately 46,000 people are living with the disease in the United States.Read more: Yahoo! News Search Results for Multiple Myeloma...

• Revlimid phase III trial in patients with multiple myeloma following autologous stem cell transplant meets primary ... (PharmaBiz)

  Automated News - Automated News

  Created: Tuesday, 22 December 2009 07:43

  Celgene Corporation announced the National Cancer Institute (NCI), a part of the National Institutes of Health, reported initial data from a phase-III, randomized, double-blind, multi-centre clinical study led by the Cancer and Leukaemia Group B (CALGB). ...

• Drug for Multiple Myeloma Demonstrated to Significantly Extend Disease-Free Survival (PhysOrg)

  Automated News - Automated News

  Created: Monday, 21 December 2009 15:41

  (PhysOrg.com) -- Initial results from a large, randomized clinical trial for patients with multiple myeloma, a cancer of the blood and bone marrow, showed that patients who received the oral drug lenalidomide (Revlimid, also known as CC-5013) following a ...

• Celgene's Boon; Genzyme Takes Flack; A Genomic Vision (Forbes)

  Automated News - Automated News

  Created: Monday, 21 December 2009 15:24

  Celgene shares are up more than 10% on news that a study sponsored by the National Institutes of HeaRead more: Yahoo! News Search Results for Multiple Myeloma...

• IMF OFFICE HOLIDAY HOURS

  Automated News - Automated News

  Created: Monday, 21 December 2009 00:00

  Read more: IMF - Home Page...

• Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival (Nature)

  Automated News - Automated News

  Created: Sunday, 20 December 2009 21:53

  MCL1 is essential for the survival of stem and progenitor cells of multiple lineages, and is unique among pro-survival BCL2 family members in that it is rapidly turned over through the action of ubiquitin ligases. B- and mantle-cell lymphomas, chronic mye...